• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Comprehensive Overview of trans-3-(methylamino)cyclobutan-1-ol (CAS No. 1033710-19-8): Properties, Applications, and Research Insights

trans-3-(methylamino)cyclobutan-1-ol (CAS No. 1033710-19-8) is a structurally unique cyclobutane derivative that has garnered significant attention in pharmaceutical and organic chemistry research. This compound, characterized by its methylamino and hydroxyl functional groups arranged in a trans configuration, serves as a versatile intermediate in drug discovery and material science. Its molecular framework, featuring a strained four-membered ring, offers intriguing reactivity patterns that are exploited in the synthesis of bioactive molecules.

Recent advancements in small-molecule therapeutics have highlighted the importance of cyclobutane-containing compounds like trans-3-(methylamino)cyclobutan-1-ol. Researchers are particularly interested in its potential to modulate protein-protein interactions (PPIs) due to its rigid geometry. The compound's stereochemistry and hydrogen-bonding capacity make it a valuable scaffold for designing enzyme inhibitors or receptor ligands, aligning with the growing demand for targeted drug delivery systems.

From a synthetic perspective, 1033710-19-8 is often utilized in asymmetric catalysis and ring-opening reactions. Its cyclobutan-1-ol moiety can undergo selective functionalization, enabling the construction of complex molecular architectures. This property resonates with current trends in green chemistry, where efficient atom economy and minimal waste generation are prioritized. Laboratories frequently search for "trans-3-(methylamino)cyclobutan-1-ol synthesis" or "CAS 1033710-19-8 applications," reflecting its relevance in modern organic methodologies.

The compound's physicochemical properties, such as its logP value and aqueous solubility, are critical for pharmacokinetic optimization. Computational studies leveraging AI-driven molecular modeling tools have predicted its compatibility with CNS targets, a hot topic in neuropharmacology research. These insights address frequently asked questions like "How does trans-3-(methylamino)cyclobutan-1-ol interact with biological membranes?" or "Is CAS 1033710-19-8 suitable for blood-brain barrier penetration?"

In material science, trans-3-(methylamino)cyclobutan-1-ol contributes to the development of smart polymers and chiral auxiliaries. Its incorporation into polymer backbones enhances thermal stability while maintaining biodegradability—a key consideration for sustainable materials. Industry professionals often explore "cyclobutanol derivatives in polymer design" or "methylamino-functionalized cyclobutanes," underscoring its cross-disciplinary utility.

Quality control of 1033710-19-8 involves advanced analytical techniques like HPLC and LC-MS, ensuring high purity for research applications. Regulatory compliance with REACH and GMP standards further solidifies its position as a reliable building block. The compound's safety profile and handling protocols are documented in SDS sheets, addressing common queries such as "Is trans-3-(methylamino)cyclobutan-1-ol stable under ambient conditions?"

Future research directions may explore 1033710-19-8 in bioconjugation strategies or as a precursor for PET radiotracers. Its structural adaptability aligns with emergent fields like precision medicine and theranostics. By integrating cutting-edge spectroscopic characterization (e.g., 2D NMR and X-ray crystallography), scientists continue to unravel new applications for this multifaceted compound.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)